Medications for Pain

Walk down any pharmacy aisle and the shelf says “pain relievers,” as if pain were one thing and relief were one substance. It isn’t, and this is the single most useful idea on this page: painkillers are not a ladder from weak to strong. They are different tools that act at different points on the pathway between an injured tissue and the brain that feels it. A medication that transforms one person’s arthritis can do nothing for another person’s nerve pain — not because either pain is less real, but because the mechanisms differ. Match the tool to the mechanism and modest drugs work well; mismatch them and even potent ones fail.

The map: where each family acts

Reading the map from left to right: at the tissue, anti-inflammatory drugs blunt the chemical alarm of injury. At the nerve, local anesthetics — and now a new drug class — quiet the signal in transit. At the spinal cord, some medications calm sensitized signaling while others strengthen the body’s own descending “brakes.” And in the brain, opioids and acetaminophen work on how loudly the alarm is experienced. The stations are the same ones described in how pain works — every pain medication ever made is an intervention somewhere on that pathway.

The everyday two: acetaminophen and the NSAIDs

Acetaminophen (Tylenol, paracetamol) is the world’s most-used pain reliever, and — remarkably — science is still debating exactly how it works; its action appears to be largely central, in the brain and spinal cord, with little effect on inflammation. Its defining safety boundary is the liver. On its own, at labeled doses, it is well tolerated; the danger is accumulation, because acetaminophen hides inside hundreds of combination cold, flu, sleep, and prescription pain products. Overdose — often unintentional — is a leading cause of acute liver failure, which is why pharmacists ask what else you are taking.

The NSAIDs — ibuprofen, naproxen, aspirin, prescription relatives, and the anti-inflammatory medicines people search for by name — work at the scene of the injury: they block the prostaglandin chemistry that makes injured tissue swell, throb, and stay tender. That mechanism makes them genuinely effective for inflammatory and tissue-driven pain — sprains, arthritis flares, dental pain, menstrual pain — and it is why guidelines list them first-line for conditions like low back pain. The same mechanism sets their limits: prostaglandins also protect the stomach lining, support the kidneys, and balance cardiovascular function, so long-term or high-dose NSAID use carries stomach, kidney, and heart cautions that deserve a clinician’s eyes — especially past middle age or alongside blood thinners.

Topicals: relief without the body-wide dose

Some of the most quietly useful pain medications never enter the bloodstream in meaningful amounts. Topical NSAID gels deliver the anti-inflammatory effect through the skin to a sore joint with a fraction of the systemic exposure. Lidocaine patches numb the nerve endings under them, useful for localized nerve pain such as post-shingles pain. Capsaicin — the chili-pepper molecule — works by overstimulating and then exhausting local pain fibers. For pain in one findable place, topicals are often worth asking about precisely because their risks stay local too.

The nerve-pain medications — and their confusing names

Here is where more pain-medication confusion lives than anywhere else. If your physician offers an “antidepressant” or a “seizure medication” for pain, nothing is being implied about your mind. These drugs earned their names from their first jobs, but they have a second, independent pharmacology. Duloxetine and the older tricyclics boost the descending pathways the spinal cord uses to dampen pain traffic — the brakes in the figure above. Gabapentin and pregabalin bind a calcium-channel subunit on overexcited neurons and turn sensitized signaling down. For pain from damaged nerves — diabetic neuropathy, sciatica-type pain, post-shingles pain — the international NeuPSIG evidence review ranks exactly these families as first-line, ahead of any conventional painkiller. NSAIDs, for all their virtues, do little for this type of pain.

Muscle relaxants, briefly

For painful muscle spasm — the seized-up back, the wry neck — clinicians sometimes add a short course of a muscle relaxant. The honest evidence summary: modest benefit for short-term use, with drowsiness as the common tax, and little support for staying on them long. They are a bridge back to movement, not a maintenance plan.

Opioids: the honest picture

Opioids — morphine and its descendants — work on the receptors of the body’s own pain-relief chemistry, turning down the alarm at the spinal cord and brain. For severe acute pain, surgical pain, cancer pain, and comfort at the end of life, they remain essential medicine, and nothing on this page argues otherwise. For long-term non-cancer pain the picture is more sobering: tolerance builds, benefits often fade, physical dependence develops with sustained use, and for a subset of people use progresses to addiction. The CDC’s 2022 guideline reframed the field away from one-size-fits-all limits and toward individualized decisions — maximizing non-opioid options first, starting low when opioids are used, and never abandoning patients who are already on them. If opioid use — yours or a loved one’s — has become hard to control, confidential help exists and works: the SAMHSA helpline, 1-800-662-4357, is free and answers around the clock.

The first new class in decades

For most of living memory, every pain pill belonged to a family your grandparents would recognize. That changed in January 2025, when the FDA approved suzetrigine (Journavx) — the first medication of a genuinely new class in over twenty years. It blocks NaV1.8, a sodium channel found on pain-sensing nerves outside the brain, muting the pain signal at its source: no opioid receptors, no euphoria, no dependence liability. Its approval covers moderate-to-severe acute pain, and its deeper significance is the door it opens — a validated non-opioid mechanism with a pipeline of successors behind it, tracked on our pain treatment pipeline.

“Strongest” is the wrong question

The most searched question about pain relievers is which one is strongest — and the figure above is the answer the question deserves. Potency measures grip on one receptor; relief comes from mechanism match. Nerve-pain drugs underwhelm for a sprained ankle. NSAIDs underwhelm for neuropathy. Opioids underwhelm for the sensitized-system pain of fibromyalgia — where movement and brain-targeted care outperform them. And because long-lasting pain is so often mixed-mechanism, real-world regimens are often thoughtful combinations of modest tools rather than one powerful one. That is not settling for less — it is how the pharmacology actually works.

Questions worth bringing to your clinician

This page describes; your clinician prescribes. The conversation goes further if you arrive with the right questions: Which mechanism do you think is driving my pain — and does this medication target it? What should improve, by when, and how will we decide whether it’s working? What are the risks with my other medications and my health history? Is a topical option worth trying first? What is the plan for stopping? A medication trial with a defined goal and an exit plan is modern pain medicine working as designed — and if your current regimen has grown without ever being re-examined, that review is exactly what a pain specialist is for.